Therapeutic implications in Parkinsonism of m-tyramine formation from L-dopa in man.
D001923:Brain Chemistry; D002845:Chromatography; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D007422:Intestines / Q000382:microbiology; D010300:Parkinson Disease / Q000188:drug therapy*; D014439:Tyramine / Q000378:metabolism* / Q000652:urine; D014443:Tyrosine / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*
D014443:Tyrosine; D004295:Dihydroxyphenylalanine; D004298:Dopamine; D014439:Tyramine